Serologicals Corporation to Present at 24th Annual JPMorgan Healthcare Conference
January 03 2006 - 10:00AM
Business Wire
Serologicals Corporation (NASDAQ:SERO) today announced that it will
present at the 24th Annual JPMorgan Healthcare Conference on
January 9, 2006. Bud Ingalls, Vice President, Finance and Chief
Financial Officer for Serologicals Corporation, will be making the
presentation. It is scheduled at 10:00 a.m. (Pacific Time) at the
Westin St. Francis, 335 Powell Street, San Francisco, California.
The presentation will be webcast and can be accessed at
http://equityconferences.jpmorgan.com on the day of the
presentation, or through the Company's website at
www.serologicals.com. Serologicals Corporation (NASDAQ: SERO),
headquartered in Atlanta, GA, is a global leader in developing and
commercializing consumable biological products, enabling
technologies and services in support of biological research, drug
discovery, and the bioprocessing of life-enhancing products. Our
customers include researchers at major life science companies and
leading research institutions involved in key disciplines, such as
neurology, oncology, hematology, immunology, cardiology,
proteomics, infectious diseases, cell signaling and stem cell
research. In addition, Serologicals is the world's leading provider
of monoclonal antibodies for the blood typing industry.
Serologicals employs a total of more than 1,000 people worldwide in
three Serologicals' companies: Chemicon International,
headquartered in Temecula, California, Upstate Group, LLC,
headquartered in Charlottesville, Virginia and Celliance
Corporation, headquartered in Atlanta, Georgia. For more
information, please visit our website: www.serologicals.com.
Serologicals (NASDAQ:SERO)
Historical Stock Chart
From Sep 2024 to Oct 2024
Serologicals (NASDAQ:SERO)
Historical Stock Chart
From Oct 2023 to Oct 2024